Earnings Feed
Start Free
Home/Filings/4/0001140361-13-025193
4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-13-025193

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:27 PM ET

Size

14.6 KB

Accession

0001140361-13-025193

Insider Transaction Report

Form 4
Period: 2013-06-11
REXAHN PHARMACEUTICALS, INC.RNN
Cheong Kwang Soo
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2013-06-11+60,000→ 60,000 total
    Exercise: $0.50Exp: 2023-06-11→ Common Stock (60,000 underlying)
Holdings

  • Common Stock

    3,000

  • Stock Options (right-to-buy)

    Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.25From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.17From: 2011-06-14Exp: 2020-06-14→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.28From: 2010-06-01Exp: 2019-06-01→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $3.24From: 2009-06-30Exp: 2018-06-30→ Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]These options vest and become exercisable in full on June 11, 2014.
  • [F2]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:27 PM ET
Size
14.6 KB
View on SEC.gov